However, there are several experimental reports that sST2 may have its own anti-inflammatory effects, e.g., direct effects on macrophages via the downregulation of Toll-like receptors, and the inhibition of LPS-induced IL-6 production in a human monocytic leukemia cell line [72,73]. This evidence concerns the gene IL6 and monocytic leukemia.